ClinConnect ClinConnect Logo
Search / Trial NCT05585853

The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery

Launched by MERSIN UNIVERSITY · Oct 14, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Pain Virtual Reality Glasses Open Heart Surgery Hemodynamic

ClinConnect Summary

This clinical trial is investigating how virtual reality (VR) glasses can help reduce pain and improve stability in patients after open heart surgery. The study will take place from January to June 2025 and will involve 82 patients who are in the cardiovascular surgery intensive care unit. To be eligible to participate, patients must be between 18 and 80 years old, speak and understand Turkish, and be on the 2nd or 3rd day after their surgery. They should also be stable, conscious, and cooperative, and have a chest tube without any sensitivity or trauma in the area where the VR glasses will be applied.

If you or a loved one qualifies for this trial, you can expect to wear VR glasses while in the hospital to see if this technology can help make the recovery process more comfortable. Participants will be monitored closely to assess their pain levels and how well their body is responding after surgery. It’s important to know that those with certain health conditions, such as active COVID-19 or specific psychiatric diagnoses, will not be able to join the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Conscious and cooperative,
  • Stable hemodynamic status,
  • Speaks and understands Turkish,
  • Over 18 years old,
  • On the 2nd and 3rd day after open heart surgery,
  • Having chest tube,
  • No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied,
  • No active COVID-19 infection,
  • Patients without any psychiatric diagnosis
  • Exclusion Criteria:
  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Not conscious,
  • Not cooperative
  • Unstable hemodynamic status,
  • Speaks and understands Turkish,
  • who are under the age of 18,
  • On the 0th or 1st day after surgery,
  • No chest tube,
  • Has sensitivity or trauma in the area (for the study group) where the virtual reality
  • Active COVID-19 infection,
  • Patients with a psychiatric diagnosis

About Mersin University

Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.

Locations

Mersin, Turkey/Mersin,Yenişehir, Turkey

Mersin, , Turkey

Patients applied

0 patients applied

Trial Officials

Gülay ALTUN UĞRAŞ, PhD

Principal Investigator

Mersin University

Sevban ARSLAN, PhD

Principal Investigator

Cukurova University

Muaz GÜLŞEN, master

Principal Investigator

Cukurova University

Firdevs Ebru ÖZDEMİR, master

Principal Investigator

Mersin University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials